Drugmaker Shuns Blockbuster Route To Find The Right Niches
When you hire a consultant to fix what's wrong with your company, rule one is take his advice. Rule two might be: Offer him a job so he can implement his own plan. Canadian-born Michael Pearson got that offer, found it one he couldn't refuse and left consulting firm McKinsey & Co. to take over as chairman and chief executive of Valeant Pharmaceuticals International (VRX) in February 2008. His plan: build a diversified pharma company in niche
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here